| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_844f1ba4fa9d58480e9d23580dcea788 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-728
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0048
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-08 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-728
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-04 |
| filingDate |
2017-10-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e3b4ee5d7e8cc4b56b57bae21b96d9b1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2af4ff4e618fd773092ccc8d97ee7350 |
| publicationDate |
2018-04-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2018069763-A1 |
| titleOfInvention |
Method for establishing, restoring, and preserving homeostasis of the ocular surface |
| abstract |
The invention concerns a method for reducing or delaying the onset of irritation, discomfort, inflammation (acute or chronic), and/or an immune response at the ocular surface by topically administering a fluid comprising high molecular weight hyaluronic acid to the ocular surface of the eye of a human or non-human animal subject, wherein the hyaluronic acid has an intrinsic viscosity of > 2.5 m 3 /kg and a concentration of < 0.2 % w/v. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021250462-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2019202017-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-112714644-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3525799-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3852725-A4
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2020157570-A1 |
| priorityDate |
2016-10-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |